Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bnt162b2 (Comirnaty) (1 trial)
mrna-1273 (Spikevax) (1 trial)
aviptadil (1 trial)
brii-196 (2 trials)
brii-198 (2 trials)
COVID-19 convalescent plasma (2 trials)
Ensovibep (1 trial)
immune globulin (human) (Gamastan) (1 trial)
Lufotrelvir (1 trial)
ly3819253 (2 trials)
remdesivir (Veklury) (8 trials)
vir-7831 (2 trials)
Influenza, Human (Phase 3)
Trials (11 total)
Trial APIs (12 total)